Which statement about nursing and trainee involvement in clinical governance best describes a correct approach?

Which statement about nursing and trainee involvement in clinical governance best describes a correct approach?

• A. Use broad-spectrum antibiotics for all infections
• B. Escalate therapy regardless of culture
• C. De-escalate therapy based on culture results
• D. Ignore resistance data

Answer: (C)

The key idea here is antimicrobial stewardship and clinical governance: use culture results to tailor antibiotic therapy rather than sticking with broad, non-specific treatment. De-escalating therapy based on culture findings means stepping down from broad-spectrum or empiric choices to a narrower, targeted antibiotic—or stopping antibiotics when they’re no longer needed—once reliable data are available. This approach protects patients from unnecessary drug exposure, reduces adverse effects, and helps limit the development of antimicrobial resistance, all of which are central to safe and effective governance in any clinical setting. Nurses and trainees contribute by supporting appropriate culture collection, monitoring patient response, reviewing interim plans with the care team, and ensuring decisions to narrow or stop therapy are documented and aligned with guidelines. This collaborative approach embodies responsible governance and patient safety. The other options describe practices that conflict with good governance and stewardship: using broad-spectrum antibiotics for all infections ignores the data and risks resistance; escalating therapy without culture support can expose patients to unnecessary risks; and ignoring resistance data undermines evidence-based care and public health goals.

The key idea here is antimicrobial stewardship and clinical governance: use culture results to tailor antibiotic therapy rather than sticking with broad, non-specific treatment. De-escalating therapy based on culture findings means stepping down from broad-spectrum or empiric choices to a narrower, targeted antibiotic—or stopping antibiotics when they’re no longer needed—once reliable data are available. This approach protects patients from unnecessary drug exposure, reduces adverse effects, and helps limit the development of antimicrobial resistance, all of which are central to safe and effective governance in any clinical setting.

Nurses and trainees contribute by supporting appropriate culture collection, monitoring patient response, reviewing interim plans with the care team, and ensuring decisions to narrow or stop therapy are documented and aligned with guidelines. This collaborative approach embodies responsible governance and patient safety.

The other options describe practices that conflict with good governance and stewardship: using broad-spectrum antibiotics for all infections ignores the data and risks resistance; escalating therapy without culture support can expose patients to unnecessary risks; and ignoring resistance data undermines evidence-based care and public health goals.